Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherRent ExpenseShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesWages, Salaries and Other
Ratios

Cannabis Bioscience International Holdings (CBIH) Receivables - Other (2025)

Cannabis Bioscience International Holdings' Receivables - Other history spans 1 years, with the latest figure at $9155.0 for Q3 2025.

  • On a quarterly basis, Receivables - Other changed N/A to $9155.0 in Q3 2025 year-over-year; TTM through Aug 2025 was $9155.0, a N/A change, with the full-year FY2025 number at $9155.0, changed N/A from a year prior.
  • Receivables - Other hit $9155.0 in Q3 2025 for Cannabis Bioscience International Holdings, roughly flat from $9155.0 in the prior quarter.
  • Over the last five years, Receivables - Other for CBIH hit a ceiling of $9155.0 in Q2 2025 and a floor of $9155.0 in Q2 2025.